BioExx Specialty Proteins Ltd., Toronto, Ontario, Canada, has received a letter from the U.S FDA wherein the agency confirmed it has no questions regarding the company’s conclusion that its canola protein products are Generally Recognized As Safe (GRAS) for use in a variety of foods and beverages. The FDA response was pursuant to a GRAS notice submitted by BioExx to FDA documenting its conclusion that Isolexx (canola protein isolate) and Vitalexx (hydrolyzed canola protein isolate) are GRAS for use in a variety of foods and beverages. The notice also included a report with such a conclusion from a panel of qualified experts. The company believes this enhancement to its product portfolio will also assist its global strategic partnering initiative.